ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) reached a new 52-week high during mid-day trading on Saturday . The stock traded as high as $10.69 and last traded at $10.49, with a volume of 11928955 shares. The stock had previously closed at $9.65.
Analyst Ratings Changes
Separately, Canaccord Genuity Group increased their price target on shares of ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a research report on Wednesday, May 21st.
Check Out Our Latest Report on ASP Isotopes
ASP Isotopes Price Performance
The company has a quick ratio of 7.17, a current ratio of 7.21 and a debt-to-equity ratio of 0.80. The stock has a market cap of $879.90 million, a P/E ratio of -17.20 and a beta of 3.35. The business's 50-day simple moving average is $7.77 and its two-hundred day simple moving average is $6.04.
Institutional Investors Weigh In On ASP Isotopes
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. AWM Investment Company Inc. boosted its holdings in shares of ASP Isotopes by 6.2% during the 1st quarter. AWM Investment Company Inc. now owns 4,511,186 shares of the company's stock valued at $21,157,000 after buying an additional 265,000 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC boosted its holdings in shares of ASP Isotopes by 11.2% during the 1st quarter. Philadelphia Financial Management of San Francisco LLC now owns 3,508,062 shares of the company's stock valued at $16,453,000 after buying an additional 354,517 shares in the last quarter. CenterBook Partners LP purchased a new position in shares of ASP Isotopes in the 4th quarter worth about $6,800,000. Exchange Traded Concepts LLC purchased a new position in shares of ASP Isotopes in the 2nd quarter worth about $9,593,000. Finally, Geode Capital Management LLC raised its position in shares of ASP Isotopes by 5.1% in the 4th quarter. Geode Capital Management LLC now owns 1,175,450 shares of the company's stock worth $5,326,000 after purchasing an additional 57,027 shares during the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Featured Articles
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
